K. Bridges

发表

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

C. Pegelow, S. Shurin, F. Barton, 2003, JAMA.

A multiparameter analysis of sickle erythrocytes in patients undergoing hydroxyurea therapy.

J. Hofrichter, W. Eaton, C. Guttmann, 1996, Blood.

Ascorbic Acid Enhances Ferritin mRNA Translation by an IRP/Aconitase Switch (*)

K. Bridges, I. Tóth, 1995, The Journal of Biological Chemistry.

Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes

J. Berlin, J. Crawford, H. Ludwig, 2010, British Journal of Cancer.

Long-Term Dosing in Sickle Cell Disease Subjects with GBT440, a Novel HbS Polymerization Inhibitor

K. Bridges, K. Dufu, J. Howard, 2016 .

Calcium regulates the commitment of murine erythroleukemia cells to terminal erythroid differentiation

D. Housman, L. Cantley, K. Bridges, 1981, The Journal of cell biology.

Darbepoetin alfa for treating chemotherapy-induced anemia in patients with a baseline hemoglobin level < 10 g/dL versus ≥10 g/dL: an exploratory analysis from a randomized, double-blind, active-controlled trial

C. Bokemeyer, P. Gascón, J. Vansteenkiste, 2009, BMC Cancer.

Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.

J. Crawford, H. Ludwig, K. Bridges, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ascorbic acid and iron metabolism: alterations in lysosomal function.

K. Bridges, K. Hoffman, K. Yanelli, 1991, The American journal of clinical nutrition.

Binding of apotransferrin to K562 cells: explanation of the transferrin cycle.

R. Klausner, K. Bridges, G. Ashwell, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Effect of iron chelators on the transferrin receptor in K562 cells.

K. Bridges, A. Cudkowicz, 1984, The Journal of biological chemistry.

Anemia in hemodialysis patients: variables affecting this outcome predictor.

W. Owen, E. Lowrie, C. Brugnara, 1997, Journal of the American Society of Nephrology : JASN.

Reticulocyte hemoglobin content (CHr): early indicator of iron deficiency and response to therapy.

O. Platt, C. Brugnara, A. Friedman, 1994, Blood.

Transfusion risk in cancer patients with chemotherapy-induced anemia when initiating darbepoetin alfa therapy at a baseline hemoglobin level of <9 g/dL versus 9 to <10 g/dL versus ≥10 g/dL: an exploratory analysis of a phase 3 trial

C. Bokemeyer, P. Gascón, J. Canon, 2012, Medical Oncology.

Adhesion of sickle neutrophils and erythrocytes to fibronectin.

D. Golan, K. Bridges, G. Barabino, 1996, Blood.

Sildenafil relieves priapism in patients with sickle cell disease.

K. Bridges, E. Bialecki, 2002, The American journal of medicine.

Asialoglycoprotein Catabolism by Hepatocytes: Insights from Perturbation of the Endocytic Pathway

R. Klausner, A. Wolkoff, K. Bridges, 1984 .

Intracellular dissociation of receptor-bound asialoglycoproteins in cultured hepatocytes. A pH-mediated nonlysosomal event.

R. Klausner, K. Bridges, G. Ashwell, 1983, The Journal of biological chemistry.

Receptor-mediated endocytosis of transferrin and the uptake of fe in K562 cells: identification of a nonlysosomal acidic compartment.

R. Klausner, K. Bridges, J. Harford, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Low concentrations of nitric oxide increase oxygen affinity of sickle erythrocytes in vitro and in vivo.

R. Kacmarek, C. Brugnara, W. Zapol, 1997, The Journal of clinical investigation.

Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 cells

D. Golan, K. Bridges, H. Thatte, 1994, Journal of cellular physiology.

Ascorbic Acid Enhances Iron-induced Ferritin Translation in Human Leukemia and Hepatoma Cells (*)

S. Abramson, K. Bridges, J. Rogers, 1995, The Journal of Biological Chemistry.

The acetylation of hemoglobin by aspirin. In vitro and in vivo.

Geoffrey, A. Cerami, H. Bunn, 1975, The Journal of clinical investigation.

Iron Overload and Chelation Therapy

K. Bridges, 2001 .

Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.

K. Bridges, B. Smith, 1985, The Journal of clinical investigation.

Reconstitution of the hepatic asialoglycoprotein receptor with phospholipid vesicles.

J. Weinstein, R. Klausner, R. Blumenthal, 1980, Proceedings of the National Academy of Sciences of the United States of America.

ATP depletion causes translational immobilization of cell surface transferrin receptors in K562 cells

D. Golan, K. Bridges, H. Thatte, 1996, Journal of cellular physiology.

Sideroblastic anemia: a mitochondrial disorder.

K. Bridges, 1997, Journal of pediatric hematology/oncology.

Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1.

H. Munro, K. Bridges, J. Rogers, 1990, The Journal of biological chemistry.

Receptor-mediated endocytosis of transferrin in K562 cells.

R D Klausner, A. Schechter, R. Klausner, 1983, The Journal of biological chemistry.

Iron metabolism in K562 erythroleukemic cells.

K. Bridges, L. Wolfe, S. Bottomley, 1985, The Journal of biological chemistry.

Sideroblastic anaemias

T. Alcindor, K. Bridges, 2002, British journal of haematology.

Ascorbic acid inhibits lysosomal autophagy of ferritin.

K. Bridges, Kenneth R. Bridges, 1987, The Journal of biological chemistry.

The effects of ascorbic acid on the intracellular metabolism of iron and ferritin.

K. Bridges, K. Hoffman, 1986, The Journal of biological chemistry.

Fate of receptor and ligand during endocytosis of asialoglycoproteins by isolated hepatocytes.

R D Klausner, R. Klausner, K. Bridges, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Nitric oxide reduces sickle hemoglobin polymerization: potential role of nitric oxide-induced charge alteration in depolymerization.

Jay X. Tang, T. Ikuta, K. Bridges, 2011, Archives of biochemistry and biophysics.

Molecular assessment of erythroid lineage chimerism following nonmyeloablative allogeneic stem cell transplantation.

J. Kutok, Catherine J. Wu, J. Ritz, 2003, Experimental hematology.

The role of cytokines in the regulation of ferritin expression.

K. Kasschau, K. Bridges, J. Rogers, 1994, Advances in experimental medicine and biology.

The use of hydrogen peroxide to enhance the efficacy of doxorubicin hydrochloride in a murine bladder tumor cell line.

K. Loughlin, K. Bridges, R. Ball, 2001, The Journal of urology.

The Acute Box cis-Element in Human Heavy Ferritin mRNA 5′-Untranslated Region Is a Unique Translation Enhancer That Binds Poly(C)-binding Proteins*

A. Thomson, P. Leedman, C. Cahill, 2005, Journal of Biological Chemistry.

Impact of Centers for Medicare & Medicaid Services national coverage determination on erythropoiesis‐stimulating agent and transfusion use in chemotherapy‐treated cancer patients

A. Collins, D. Gilbertson, Shuling Li, 2012, Pharmacoepidemiology and drug safety.

Transfer ribonucleic acids from mouse plasmacytoma tumors producing kappa and immunoglobulin chains.

K. Bridges, G. Jones, 1973, Biochemistry.

Chloramphenicol‐induced mitochondrial dysfunction is associated with decreased transferrin receptor expression and ferritin synthesis in K562 cells and is unrelated to IRE‐IRP interactions

D. Golan, K. Bridges, L. Leiter, 1999, Journal of cellular physiology.

Hypoxia Alters Iron-regulatory Protein-1 Binding Capacity and Modulates Cellular Iron Homeostasis in Human Hepatoma and Erythroleukemia Cells*

K. Bridges, J. Rogers, I. Tóth, 1999, The Journal of Biological Chemistry.

Case series of patients with severe sickle cell disease treated with voxelotor (GBT440) by compassionate access

K. Bridges, G. Blyden, Lanetta Bronte, 2018, American journal of hematology.

Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy‐induced anemia

T. Ciuleanu, P. Silberstein, K. Bridges, 2010, American journal of hematology.

Effects of alterations in cellular iron on biosynthesis of the transferrin receptor in K562 cells

R. Klausner, K. Bridges, E. Mattia, 1985, Molecular and cellular biology.

Kidney transplant from sickle cell trait donor to sickle cell trait recipient.

K. Bridges, S. Al-Ghamdi, M. Kelta, 2007, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

Hospitalization Rates for Newly Diagnosed Multiple Myeloma Patients in the United States Medicare Database

K. Bridges, Winifred Werther, A. Yusuf, 2015 .

Heparin use and venous thromboembolism (VTE) among cancer patients receiving chemotherapy with a prior history of VTE.

K. Bridges, J. Fryzek, J. Dietrich, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of Erythropoiesis-stimulating Agents (ESAs) in Lung Cancer Patients: Study-level and Patient-level Meta-analyses of Safety Outcomes

J. Crawford, H. Ludwig, K. Bridges, 2010 .

A retrospective analysis to examine factors associated with mortality in Medicare beneficiaries newly diagnosed with multiple myeloma

K. Bridges, Yi Peng, Winifred Werther, 2016, Current medical research and opinion.

Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.

R. Dluhy, S. Rabinowe, K. Bridges, 1985, Archives of internal medicine.

Regulation of the transferrin receptor in K562 erythroleukemia cells.

R. Klausner, K. Bridges, A. Cudkowicz, 1984, Progress in clinical and biological research.

Pooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.

J. Crawford, H. Ludwig, K. Bridges, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.